LINC00957

ncRNA information

ncRNA name

LINC00957

Specific or universal ncRNAs

Specific ncRNAs

Class

Long noncoding RNA

Biomarker

Yes

Biomarker application

Diagnosis/Treatment

Upstream regulatory factors

Not available

Downstream target

P-gP

Cancer information

Cancer name

Colorectal Cancer

Cancer site

Colon, Rectum, and Anus

Treatment information

Treatment type

Chemotherapy

Drug

5-Fluorouracil

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Down

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Mechanically, inhibition of LINC00957 expression reversed 5-FU resistance by down-regulating P-gP.

Tissue resource

colorectal cancer tissues and adjacent normal tissues

human colorectal cancer cell lines HCT8

human colorectal cancer cell lines SW480

human colorectal cancer cell lines SW620

human colorectal cancer cell lines LOVO

human colorectal cancer cell lines HCT116

normal human colon epithelial cell lines NCM460

human colorectal cancer 5-Fu-resistant cell lines HCT-8/5-Fu

Experiment

qRT-PCR,Western blot


Institute

the Affiliated Hospital of Jiangnan University

Nanjing Musai Bio-Tech Co, Ltd

Keygen Biotech Co. Ltd

Country

China

Continent

Asia